Loading menu…

Hyperuricemia in Type 2 Diabetes Mellitus

Kashinath R. T.
Kashinath R. T. § Msc Biochemistry, Ph.D. Biochemistry (Medical Faculty), FICS
§ Department of Biochemistry, Subbaiah Institute of Me...
‡ Department of Medicine, Subbaiah Institute of Medica...
Department of Dermatology, Subbaiah Institute of Med...

Send Message

To: Author

Hyperuricemia in Type 2 Diabetes Mellitus

Article Fingerprint

ReserarchID

PDDTM29O4S

Hyperuricemia in Type 2 Diabetes Mellitus Banner

Key Research Insights

Synthesized scholarly intelligence & interactive research assistant
  • English
  • Afrikaans
  • Albanian
  • Amharic
  • Arabic
  • Armenian
  • Azerbaijani
  • Basque
  • Belarusian
  • Bengali
  • Bosnian
  • Bulgarian
  • Catalan
  • Cebuano
  • Chichewa
  • Chinese (Simplified)
  • Chinese (Traditional)
  • Corsican
  • Croatian
  • Czech
  • Danish
  • Dutch
  • Esperanto
  • Estonian
  • Filipino
  • Finnish
  • French
  • Frisian
  • Galician
  • Georgian
  • German
  • Greek
  • Gujarati
  • Haitian Creole
  • Hausa
  • Hawaiian
  • Hebrew
  • Hindi
  • Hmong
  • Hungarian
  • Icelandic
  • Igbo
  • Indonesian
  • Irish
  • Italian
  • Japanese
  • Javanese
  • Kannada
  • Kazakh
  • Khmer
  • Korean
  • Kurdish (Kurmanji)
  • Kyrgyz
  • Lao
  • Latin
  • Latvian
  • Lithuanian
  • Luxembourgish
  • Macedonian
  • Malagasy
  • Malay
  • Malayalam
  • Maltese
  • Maori
  • Marathi
  • Mongolian
  • Myanmar (Burmese)
  • Nepali
  • Norwegian
  • Pashto
  • Persian
  • Polish
  • Portuguese
  • Punjabi
  • Romanian
  • Russian
  • Samoan
  • Scots Gaelic
  • Serbian
  • Sesotho
  • Shona
  • Sindhi
  • Sinhala
  • Slovak
  • Slovenian
  • Somali
  • Spanish
  • Sundanese
  • Swahili
  • Swedish
  • Tajik
  • Tamil
  • Telugu
  • Thai
  • Turkish
  • Ukrainian
  • Urdu
  • Uzbek
  • Vietnamese
  • Welsh
  • Xhosa
  • Yiddish
  • Yoruba
  • Zulu
Reading Preferences
Font Size
Line Spacing
Background

References

37 Cites in Article
  1. 1. R. Kashinath (1972). Whole blood uric acid levels in diabetics with or without lipaemia. J. Mys. Med. J. Mys. Med. Assoc, 36, 153-156.
  2. 2. Kertes J,Jhonson M (2007). Evidence based Eye care. Evidence-Based Eye Care
  3. 3. Butturini U,Coscelli I (1977). Insulin release in hyperuricemic patients. Acta. Diabetol. Lat, 14, 73-78.
  4. 4. D. Sinagra,D. Greco,A. Scarpitta (1996). Serum uric acid, insulin secretion and resistance in non-hyperuricemia and hyperuricemic obese female subjects. Int. J. Obes. Relat. Int. J. Obes. Relat. Metab.Disord, 20, 1041-1043.
  5. 5. M. Wang,O. Zhao,Wang Lin,J. Lin,S. (2007). A prospective study on relationship between blood uric acid levels, insulin sensitivity and insulin resistance. Chinese Journal of Internal Medicine, 46, 824-826.
  6. 6. G. Quinones,A. Natali,S. Baldi,S. Frascerra,G. Sanna,D. Ciociaro,etal (1995). Effect of insulin on uric acid excretion in humans. Am. J. Endocrinol. Metab, 268, 1-E5.
  7. 7. J. Medelie,C. Papier,U. Goldbourt,J. Herman (1975). Major factors in the development of diabetes mellitus in 10000 men. Arch. Int. Med, 135, 811-17.
  8. 8. Herman B,Medelie U (1976). Diabetes, prediabetes and uricaemia. Diabetologia, 12(1), 47-52.
  9. 9. Toumilehto J,Zimmet P,Wolf E,Taylor R,Ram P,King H (1988). PLASMA URIC ACID LEVEL AND ITS ASSOCIATION WITH DIABETES MELLITUS AND SOME BIOLOGIC PARAMETERS IN A BIRACIAL POPULATION OF FIJI. Epidemiol, 127, 321-336.
  10. 10. N. Nakanishi,M. Okamoto,H. Yoshida,Y. Matsuo,K. Suzuki,K. Tatara (2003). Serum uric acid and risk for development of hypertension and impaired fasting glucose or type II diabetes in Japanese male office workers. Eur. J. Epidemiol, 18, 523-530.
  11. 11. E. Boyko,M. de Courten,P. Zimmer P Z, Chitson,K. TonmilhetoJ&Alberti (2000). Features of the metabolic syndrome predict higher risk of diabetes and impaired glucose tolerance - a prospective study in Maurtius. Diabetes Care, 23, 1242-1248.
  12. 12. Dehgan A,Von M,Sjibrands G,Hofman M (2008). High Serum Uric Acid as a Novel Risk Factor for Type 2 Diabetes. Diabetes Care, 31(2), 361-362.
  13. 13. Chein L,Chan E,Hsu etal (2008). Plasma Uric Acid and the Risk of Type 2 Diabetes in a Chinese Community. Chem, 54, 310-316.
  14. 14. Kramer K,Van D (2009). Serum Uric Acid Levels Improve Prediction of Incident Type 2 Diabetes in Individuals With Impaired Fasting Glucose: The Rancho Bernardo Study. Diabetes Care, 32(10), e126-e126.
  15. 15. Saih Kodama S,Yachi etal (2009). Association Between Serum Uric Acid and Development of Type 2 Diabetes. Diabetes Care, 32(9), 1737-1742.
  16. 16. M. Modan,H. Halkin,A. Karasik,A. Lusky Elevated serum uric acid ? a facet of hyperinsulinaemia. Diabetelogia, 30(9), 713-718.
  17. 17. Pavani Shankar (2011). Association between serum uric acid levels and diabetes mellitus. I. J. Endocrinol, 2011, 1-6.
  18. 18. Feldman Jerome,&heroldlebrovitz (1971). Clin. Res, 19(2), 474.
  19. 19. Cited in Practical Clinical Biochemistry by Herold Varley, 4th Edn. page, 82-83.
  20. 20. T. Caraway (1967). cited in Practical Clinical Biochemistry by Herold Varley, 3rdEdn, page :205. Biochemistry
  21. 21. Giusti G (1974). Estimation of adinosinedeaminase cited in Methods of enzymatic analysis. Methods of Enzymatic Analysis, 2, 1092-1099.
  22. 22. E. Campbell (1967). cited in Practical Clinical Biochemistry by Herold Varley, 3rdEdn. Clinical Biochemistry, 1, 465-466.
  23. 23. Brownlee M (2001). Biochemistry and molecular cell biology of diabetic complications. Nature, 414, 813-820.
  24. 24. L. Ronald,Huey Jenkins,Stanley McDaneil,Wayne Digerness,&. Parrish,L. Richard,Ong (1988). Adenine nucleotide metabolism in hearts of diabetic rats. Diabetes, 37, 629-636.
  25. 25. Warrior C,Rao Y,Kulpati S (1995). Evaluation of adenosine deaminase activity and lipid peroxidation levels in diabetes mellitus. Indian Journal of Clinical Biochemistry, 10(1), 9-13.
  26. 26. M. Goen,H. Sirajwala,J. Kalaria (2013). A study of serum adenosoinedeaminaselevels in patients with type 2 diabetes mellitus and its correlation with glycemic control. Ind. J. Med. App. Ind. J. Med. App. Sci, 2(3), 259-267.
  27. 27. N. Kurtel,S. Pence,E. Akarsu,etal (1977). Adenosine deaminase activity in lymphocytes. Br. J. Haematol, 37, 157-158.
  28. 28. Brein M,Granner K (1991). Regulation of gene expression by insulin. Biochem. J, 278, 609-619.
  29. 29. Mahdev K,Zilbering A,Zhu L,Goldstein J (2001). Insulin-stimulated Hydrogen Peroxide Reversibly Inhibits Protein-tyrosine Phosphatase 1B in Vivo and Enhances the Early Insulin Action Cascade. Chem, 276, 1938-2194.
  30. 30. Meng C,Fukuda NK (2002). Reversible Oxidation and Inactivation of Protein Tyrosine Phosphatases In Vivo. Molecular Cell, 9, 387-389.
  31. 31. Meng C,Buckley DA,Galic S,Tiganis NK (2004). Regulation of insulin signaling through reversible oxidation of the protein tyrosine phosphatases TC 45 and PTP1B. J.Biol. Chem, 279, 7716-3772.
  32. 32. Zengchang Hairong Nan,WeignoGao Shaojie Wang,JieRen LeiZang,Jakko Feng Ning,Qing Qiao (2010). Diabetes & Vascular Disease Research. Diabetes & Vascular Disease Research, 7(1), 40-46.
  33. 33. M. SudhindraRao,John Sahayo (2012). A study of Serum uric acid in diabetes mellitus and pre-diabetes in a south Indian tertiary care hospital. Nitte University Journal of Health Science, 2(2), 18-23.
  34. 34. Abdul Jalai,Safi,Rashid Mohmood,Mudassir Ahmed Khan &Amin-ul-Haq (2004). Association of Serum uric acid with type 2 diabetes mellitus. JPMI, 18(1), 59-63.
  35. 35. Clark D,&Stoerk HC (1956). The uptake of P32 by nucleic acids of Lymphoid tissue undergoing atrophy. J. Biol. Chem, 222, 285-292.
  36. 36. P. Fao,G. Galasino,E. Costa (1955). Prolactin and secretion of insulin and glucagon by the pancreas. Am. J. Physiol, 182, 493-496.
  37. 37.

Funding

No external funding was declared for this work.

Conflict of Interest

The authors declare no conflict of interest.

Ethical Approval

No ethics committee approval was required for this article type.

Data Availability

Not applicable for this article.

How to Cite This Article

Nagendra. S., Kashinath R. T., Srinivas. S.. 2014. "Hyperuricemia in Type 2 Diabetes Mellitus". Global Journal of Medical Research - B: Pharma, Drug Discovery, Toxicology & Medicine GJMR-B Volume 14 (GJMR Volume 14 Issue 14 (B3)).

More Citation Formats

Download Citation

Journal Specifications

Crossref Journal DOI 10.17406/gjmra

Print ISSN 0975-5888

e-ISSN 2249-4618

Keywords
Classification
GJMR-B Classification NLMC Code: WD 200
WK 810
Version of record
v1.2

Issue date
March 31, 2014

Language
English
Order Article Reprint
Experience in AR

Explore published articles in an immersive Augmented Reality environment. Our platform converts research papers into interactive 3D books, allowing readers to view and interact with content using AR and VR compatible devices.

Read in 3D

Your published article is automatically converted into a realistic 3D book. Flip through pages and read research papers in a more engaging and interactive format.

Article Matrices
Total Views: 2.2K
Total Downloads: 133
All Trends

Request Access

Please fill out the form below to request access to this research paper. Your request will be reviewed by the editorial or author team.
X

This is the heading

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

High-quality academic research articles on global topics and journals.

Hyperuricemia in Type 2 Diabetes Mellitus